期刊文献+

多索茶碱治疗呼吸系统喘息性疾病的疗效观察 被引量:11

下载PDF
导出
摘要 目的观察氨茶碱和多索茶碱治疗呼吸系统喘息性疾病的临床效果和安全性。方法多索茶碱与氨茶碱进行对比观察,治疗组采用多索茶碱300mg加入5%的葡萄糖注射液250m l中静脉滴注,1次/d,用药7d;对照组采用氨茶碱注射液,每次250mg加入5%葡萄糖注射液250m l中静脉滴注,用药7d,观察两组患者临床疗效和肺功能参数、不良反应。结果治疗组总有效率89.8%、对照组71.7%;第1秒用力呼气量(FEV1)用/力肺活量(FVC),治疗组总有效率为87.8%、对照组为73.7%,而不良反应发生率明显低于对照组。治疗组与对照组之间有显著性差异(P<0.05)结论多索茶碱治疗支气管哮喘和慢性阻塞性肺病疗效显著,不良反应少,临床应用安全有效。
出处 《实用心脑肺血管病杂志》 2011年第7期1160-1161,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献6

二级参考文献8

  • 1[1]Melbye H,Halvorsen DS,Hartz I,et al.Bronchial airflow limitation,smoking,body mass index,and statin use are strongly associated with the C-reactive protein level in the elderly.The Tromso Study 2001[J].Respiratory Medicine,2007,101 (3):2541-2549.
  • 2[2]Hauber HP,Goldmann T,Vollmer E,et al.Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa[J].American Journal of Respiratory Cell and Molecular Biology,2007,37 (10):606-616.
  • 3[3]Casoni GL,Poletti V.Dexamethasone for bronchiolitis[J].The New England Journal of Medicine,2007,357 (6):1659-1665.
  • 4[4]Yao YY,Liu DM,Xu DF,et al.Memory and learning impairment induced by dexamethasone in senescent but not young mice[J].European Journal of Pharmacology,2007,574 (7):20-28.
  • 5[5]Kjetil H,Sem TK,Ellen S,et al.The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery[J].Anesthesia & Analgesia,2007,105 (8):481-486.
  • 6[6]Singh RR,Moritz KM,Bertram JF,et al.Effects of dexamethasone exposure on rat metanephric development:in vitro and in vivo studies[J].American Journal of Physiology,2007,293 (13):548-554.
  • 7卫生部药政局.镇咳、平喘药物临床研究指导原则[C].新药(西药)临床及临床前研究指导原则汇编,1993.51-53.
  • 8儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2372

共引文献8651

同被引文献64

  • 1刘澄英,谢伟国,谢诤,江莲.多索茶碱治疗慢性阻塞性肺疾病74例效果分析[J].南通大学学报(医学版),2008,28(4):305-306. 被引量:19
  • 2江莲,谢伟国,侯昕珩,华琼.多索茶碱治疗支气管哮喘60例临床观察[J].南通大学学报(医学版),2009,29(2):153-155. 被引量:15
  • 3邹同祥.用多索茶碱与氨茶碱治疗支气管哮喘的疗效对比[J].当代医药论丛,2014,12(9):254-255. 被引量:10
  • 4Shukla D,Chakraborty S,Singh S,et al.Doxofylline:a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease[J].Expert Opin Pharmacother,2009,10(14):2343-2356.
  • 5Konradsen JR,James A,Nordlund B,et al.The chitinase-like protein YKL-40:A possible biomarker of inflammation and airway remodeling in severe pediatric asthma[J].J Allergy Clin Immunol,2013,132(2):328-335.
  • 6袁晓春,杨丽君,邓银华,王凯,张青.氨茶碱治疗支气管哮喘的血药浓度监测与疗效分析[J].医学临床研究,2007,24(10):1807-1808. 被引量:14
  • 7Braun-Fahrlnder C.The role of the microbial environment for the development of childhood asthma and allergies[J].Ther Umsch,2013,70(12):714-719.
  • 8Tsicopoulos A,de Nadai P,Glineur C.Environmental and genetic contribution in airway epithelial barrier in asthma pathogenesis[J].Curr Opin Allergy Clin Immunol,2013,13(5):495-499.
  • 9Scott M,Roberts G,Kurukulaaratchy RJ,et al.Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18years[J].Thorax,2012,67(12):1046-1051.
  • 10Cheng SL,Wang HC,Kuo SH,et al.Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy:an openlabel pilot study[J].Drug Des Devel Ther,2013,17(7):477-484.

引证文献11

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部